No profile data available.
Disc Medicine, Inc. (IRON) is a healthcare company in the metabolic process treatment drugs industry, based in Watertown, United States, with about 165 full-time employees.
It reported revenue of $0 for fiscal year 2025, and net income of -$212.18 million. Its market capitalization was $2.38 billion as of October 9, 2026.
Figures from company filings and market data; latest fiscal year ended December 31, 2025; market data as of October 9, 2026.
, together with its subsidiaries, a clinical-stage biopharmaceutical company, engages in the discovery, development, and commercialization of novel treatments for patients suffering from serious hematologic diseases in the United States.
Disc Medicine reported $0 in revenue for fiscal year 2025.
$2.38 billion as of October 9, 2026.
Listed companies of a similar size in the same industry (metabolic process treatment drugs) include BioMarin Pharmaceutical Inc. (BMRN), NewAmsterdam Pharma Company N.v. (NAMS), Maze Therapeutics, Inc. (MAZE), Zevra Therapeutics, Inc. (ZVRA).